Dientamoebiasis medical therapy: Difference between revisions
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | ==Medical Therapy== | ||
;Shown below is a table summarizing the empiric treatment for dientamoebiasis.<ref>http://www.cdc.gov/parasites/dientamoeba/health_professionals/</ref> | |||
{| class="wikitable" border="1" style="background:FloralWhite" | |||
|- align="center" | |||
|'''Pathogens''' | |||
|'''Preferred Treatment''' | |||
|'''Duration of Treatment''' | |||
|- align="center" | |||
| Dientamoeba fragilis | |||
| '''[[Iodoquinol]]''' 650 mg orally 3 times daily | |||
'''OR''' | |||
'''[[Paromomycin]]''' 25–35 mg per kg per day orally, in 3 divided doses | |||
'''OR''' | |||
'''[[Metronidazole]]''' (2) 500–750 mg orally 3 times daily | |||
|'''[[Iodoquinol]]''' for 20 days | |||
'''OR''' | |||
'''[[Paromomycin]]''' for 7 days | |||
'''OR''' | |||
'''[[Metronidazole]]''' for 10 days | |||
|} | |} | ||
(1). Not FDA-approved for this indication. | (1). Not FDA-approved for this indication. | ||
Revision as of 15:40, 29 November 2012
|
Dientamoebiasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dientamoebiasis medical therapy On the Web |
|
American Roentgen Ray Society Images of Dientamoebiasis medical therapy |
|
Risk calculators and risk factors for Dientamoebiasis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: : Kalsang Dolma, M.B.B.S.[2]
Overview
Medical Therapy
- Shown below is a table summarizing the empiric treatment for dientamoebiasis.[1]
| Pathogens | Preferred Treatment | Duration of Treatment |
| Dientamoeba fragilis | Iodoquinol 650 mg orally 3 times daily
OR Paromomycin 25–35 mg per kg per day orally, in 3 divided doses OR Metronidazole (2) 500–750 mg orally 3 times daily |
Iodoquinol for 20 days
OR Paromomycin for 7 days OR Metronidazole for 10 days |
(1). Not FDA-approved for this indication.
(2). Metronidazole is a nitroimidazole drug. The nitroimidazole drugs secnidazole and ornidazole have been used to treat D. fragilis infection but are unavailable in the United States.
External Link
http://www.cdc.gov/parasites/dientamoeba/health_professionals/index.html